2017 Call for Workshops - Now Closed
ASPHO will not be accepting proposals at this time.
The 30th Annual Meeting
April 26-29, 2017
Palais des congrès de Montréal
The American Society of Pediatric Hematology/Oncology will hold its 30th Annual Meeting, April 26-29, 2017, in Montreal, Quebec, Canada. The ASPHO Program Committee invites the submission of proposals for workshops to be presented during the meeting in Montreal.
The Program Committee requests that proposals for workshops be interactive problem-solving discussions, debates, cases, etc. that are geared towards the educational needs of a specific audience. Topics can focus on individual diseases, clinical trial updates, disease registries, or professional development. Workshop proposals will be scored based on content and planned audience engagement. Panel participants should represent a varied group of faculty (e.g.; multiple institutions).
All workshops will have one person assigned from the Program Committee to provide oversight to ensure interactivity, review presentation slides two weeks prior to the meeting, verify that the presenters provide a balance between clinical and biology during the session, and verify that no more than two people from one institution will be represented.
Speaker Reimbursement Policy
- Each session is limited to a moderator and up to 3 additional speakers (3 members, 1 non-member).
- Member speakers will receive $250 honorarium for their participation in the workshop.
- Non-members who are pediatric hematologists/oncologists will receive $250 honorarium for their participation in the workshop.
- Non-members who are NOT pediatric hematologists/oncologists will receive: $250 honorarium, one round trip coach airfare, one hotel night at the meeting hotel, and meeting registration.
- Any submissions differing from this policy will need to have written documentation supporting the need and must be approved by the Board of Trustees.
Submissions will need to include a clearly articulated rationale for the session, which describes the need and intended outcome. As part of your description you will be asked to answer these questions:
- What is the gap or problem that exists and how will it be addressed?
- Why is that? What is causing this to occur?
- What will learners be able to do with this information?
You will also be asked to provide one source of data which speaks to the need for this topic (this can be needs assessment data, statistics regarding the topic, etc.)
The submittal system will remain open from June 14 to August 4, 2016. The system will close at 11:59 am Pacific Time on the deadline date and additional submissions will not be accepted.
Applicants will be notified in September of 2016 regarding selection of their workshop.
Faculty Disclosure Requirements
The American Society of Pediatric Hematology/Oncology requires full faculty disclosure and a speaker agreement and from all faculty. Completed disclosure forms and speaker agreement must be received by August 18, 2016 to be reviewed and discussed for potential and real conflicts of interest by the Education Committee. Please note that the submission system will close on August 4, but the forms will remain accessible to faculty until August 18, 2016. Faculty members failing or refusing to complete the forms will be prohibited from participating in the meeting. The American Society of Pediatric Hematology/Oncology requires that all contributions to a CME activity are based on the best available evidence (refer to Policy on Content Validation).
All proposed speakers named on this proposal will receive an e-mail notice which instructs each of them, individually, to visit the proposal before the August 18, 2016 submission deadline to complete their disclosure form and speaker agreement. This notice will be sent to all speakers as soon as the submission forms are complete and the "Submit this Proposal now for review" button has been selected. Additionally, moderators should contact the speakers named on the proposal to notify them of their inclusion in the submission and to remind them to complete their disclosure information and speaker agreement before the August 18 deadline.
Proposals for Workshops
Workshops are scheduled to take place Wednesday, April 26- Saturday, April 29, 2017. All faculty must be willing and able to present on these dates. Workshop sessions are 90 minutes in length.
For each submission, you will be asked for:
- Presentation title
- Presentation description (75 words for publication in the conference brochure).
- Learning objectives (2-3 statements defining the expected outcomes)
- Information source
- Agree to work with a member of the Program Committee for oversight of your workshop. You and your speakers will be expected to submit your presentation slides to this committee member two weeks prior to the meeting
- Presentation outlines (a minimum of half the time should be interaction with cases, debates, etc.)
- Provide details on how you plan to make your workshop interactive
- Proposed Young Investigator to be involved in the planning and implementation of this workshop (including title, institution and contact information)
- Moderator and presenter contact information (include: name, credentials, employer, address, phone, fax, email, and if different from above- presentation title)
- If more than one speaker is from the same institution, please justify why you feel this is necessary
The Program Committee has identified the following symposia sessions for the 2017 meeting:
- Cancer predisposition
- Overcoming immune resistance
- Liver tumors
- Equipoise in clots
- AYA complications in Sickle Cell Disease
- New genes and genetic disorders
- Platelet/genetic disorders
- Anti-viral, anti-fungal, and other supportive anti-infective approaches
- Difficult cases in palliative care
- Gene editing
- Transforming racial disparities
- Allogeneic transplantation
The Program Committee suggests the following workshops, but will consider other topics as well:
- Relapsed sarcoma
- Bleeding disorders
- NOAC (DOACS)
- Non-conventional bleeding D/O therapies
- Heme manifestations of non-heme disorders (e.g. celiac disease, eosinophilia)
- Precision medicine and pediatric oncology
- CML: transplant vs non transplant approaches and other myeloproliferative disorders
- Newborn genomics screening (ethics, consent, actionable info.)
- Iron overload (includes transfusion)
- Haploidentical transplants
For questions regarding the ASPHO meeting or your proposal, please contact ASPHO Member Services, 847.375.4716.